ZETA shareholder plans sale of 4,000 Class A shares on NYSE
A shareholder related to ZETA has filed a notice of intent to sell 4,000 shares of Class A Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
A shareholder related to ZETA has filed a notice of intent to sell 4,000 shares of Class A Common Stock. The shares are to be sold through Merrill Lynch on the NYSE, with an aggregate market value of $81,920 based on the referenced price, and an approximate sale date of 01/02/2026. The filing identifies the shares as originally acquired on 04/21/2023 via estate planning transfers from the settlor of the trust.
The person for whose account the shares are being sold represents that they are not aware of any material adverse, nonpublic information about the issuer’s current or prospective operations. The notice also reports that the Southbeach Trust R6 previously sold 1,115 shares of Class A Common Stock on 12/19/2025 for gross proceeds of $19,922.53.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does ZETAs latest Form 144 filing disclose?
What prior sales of ZETA stock are reported in the past three months?
Does the seller claim to have any undisclosed negative information about ZETA?
AI-generated analysis. How Rhea-AI works. Not financial advice.